Journal of International Oncology ›› 2017, Vol. 44 ›› Issue (8): 682-685.doi: 10.3760/cma.j.issn.1673422X.2017.09.010

Previous Articles     Next Articles

Anticancer properties of fenofibrate

Shen Yating, Hu Duanmin   

  1. Department of Gastroenterology, Second Affiliated Hospital of Soochow University, Suzhou 215004, China
  • Online:2017-09-08 Published:2017-10-31
  • Contact: Hu Duanmin E-mail:huduanmin@163.com
  • Supported by:

    Science and Technology Planning Project of Suzhou of China (SYS201632)

Abstract: Fenofibrate is a common lipidlowing drug activating peroxisome proliferatoractivated receptor alpha (PPRAα). Recent studies have found that fenofibrate possesses anticancer properties. Its specific mechanisms include inhibiting cell metabolism and formation of new tumor vessels, arresting cell circle, weakening cell motility, and inducing cell apoptosis. Those properties are partly independent of PPRAα. Due to its low sideeffects, it′s hopefully to be used as an anticancer adjuvant drug.

Key words: Procetofen, Neoplasms, Apoptosis, Cell cycle